Latest News and Press Releases
Want to stay updated on the latest news?
-
Houston, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced the completion of the first procedure...
-
TRE-515, the only dCK inhibitor in development, secures $1.8M NIH grant after outperforming market-leader Stelara in Crohn’s studies.
-
Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "Gastroenterology - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Gastroenterology was...
-
Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Barrett's Esophagus - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Barrett's Esophagus...
-
Appendicitis Treatment Market Growth and Emerging Trends Analysis 2025-2030: A $5.4 Billion Industry
Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Appendicitis Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Appendicitis...
-
Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Diverticulitis Disease - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Diverticulitis...
-
Castle will share new data on its TissueCypher Barrett’s Esophagus test via a podium presentation on Sept. 13 at the AFS 2025 Annual Meeting.
-
EXTON, PA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The recent approval of Novo Nordisk’s Wegovy (semaglutide 2.4mg) as the second treatment for metabolic dysfunction-associated steatohepatitis (MASH)...
-
EXTON, PA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Patients with inflammatory bowel disease (IBD) in the US are taking a more active role than ever before in the decision to switch their advanced...
-
EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The Crohn’s disease (CD) treatment landscape is undergoing a radical transformation as newer mechanisms of action (MOAs), particularly IL-23 inhibitors...